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chemistry for rapid and selective acylation of
intracellular natural proteins†
Yousuke Takaoka,‡a Yuki Nishikawa,a Yuki Hashimoto,a Kenta Sasakia
and Itaru Hamachi*ab
A rapid and selective ligand-directed chemical reaction was developed for the acylation of proteins in living
cells on the basis of ligand-directed chemistry. By fine tuning the reactivity and stability of the phenyl ester
derivatives, we successfully identified ortho-dibromophenyl benzoate as the optimal reactive motif. It was
sufficiently stable in an aqueous buffer, hydrolyzing less than 10% after 13 h of incubation, but reactive
enough for efficient and selective protein labeling in living mammalian cells, as well as in vitro (referred
to as ligand-directed dibromophenyl benzoate (LDBB) chemistry). Using this chemistry, various
fluorophores can be tethered to the target protein directly, which allows fluorescence visualization of
the labeled protein in live cells using different colored fluorophore groups (including coumarin,
fluorescein and rhodamine). Furthermore, this labeling is applicable to not only an overexpressed protein
(E. coli dihydrofolate reductase) but also endogenous human carbonic anhydrase II and XII under living
cell conditions. LDBB chemistry is a new entry of ligand-directed protein labeling methods, and should
be particularly useful for the imaging of natural proteins in living cells.
Introduction
Natural protein labeling by synthetic uorophores in living cells
is powerful for investigating protein localization, quantication
or function under native conditions, owing to the small size,
variety of colors or micro-environment sensitivity of uo-
rophores, which are distinct from uorescent proteins.1–3 We
have recently proposed ligand-directed (LD) chemistry as a new
strategy for the non-invasive and specic labeling of endoge-
nous proteins in live cells. In particular, ligand-directed tosyl
(LDT) chemistry allowed for covalent labeling of natural
proteins with synthetic uorophores, by which we constructed a
semisynthetic biosensor inside living cells.4 Fluorophore teth-
ering to natural membrane-bound proteins was also carried out
using recently developed ligand-directed acyl imidazole (LDAI)
chemistry.5 Fenical and co-workers independently reported
another type of LD chemistry using a phenyl-ester (LDPE) for
the identication and visualization of a natural product target
protein.6 Despite their high selectivity, these methods oen
suffer from slow reaction rates (about 10 h of reaction time) and
low labeling efficiency, which hampers the uorescent imaging
of intracellular proteins.4,5On the other hand, simply increasing
the reactivity of the labeling reagents to accelerate the reaction
would result in non-specic reactions toward non-target
proteins and/or nonproductive hydrolysis of the reagents.
Clearly, for the selective imaging of “intracellular” protein using
LD chemistry, a balanced reactive motif equipped with the two
conicting capabilities, selectivity and fast kinetics, is
required.7
Toward this goal, we focused on protein acylation using
Fenical's LDPE chemistry because the phenyl esters can
potentially modify Lys residues, which are oen abundant on
protein surfaces8 and sufficiently reactive under the physiolog-
ical conditions.9 We sought to tune both the reactivity and
stability of the LDPE reagents, in order to obtain optimal PE
derivatives for “selective but rapid” intracellular protein
labeling (Fig. 1a). The reactivity of the substituted PE group was
initially controlled by changing the substituent on the phenol
ring (Fig. 1b, part A). The stability was optimized by using
sterically hindered PE esters composed of an “ortho”-
substituted phenol and an alkyl/benzoic acid, both of which are
expected to be effective for minimizing nonspecic reactions
and enzymatic decomposition (Fig. 1b, part B). From the
screening of several LDPE reagents, ortho-dibromophenyl
benzoate derivatives were found to exhibit the moderate reac-
tivity required for selective and rapid protein acylation of
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dihydrofolate reductase (eDHFR) in E. coli cell lysates, as well as
in vitro. By using this Ligand-Directed diBromophenyl Benzoate
(LDBB) chemistry, we successfully labeled and imaged not only
overexpressed eDHFR as a model protein, but also endoge-
nously expressed human carbonic anhydrase II and XII (hCAII,
XII) in living mammalian cells.
Results and discussion
Molecular design of ortho-substituted phenyl ester reagents
Escherichia coli dihydrofolate reductase (eDHFR) and trimeth-
oprim (TMP) were chosen as the initial target–ligand pair for
screening of the reaction moieties because this ligand–protein
binding is known to be specic even in mammalian cells (the Kd
value was about 10 nM), and a reactive Lys is located near the
ligand binding pocket of eDHFR.10–12 Accordingly, we designed
four types of new reagents 1–4 containing a TMP ligand and a
synthetic uorophore (7-diethylaminocoumarin (Dc)), con-
nected with ortho-substituted phenyl ester linkers, such as 3,5-
dichloro-, 3-nitro-, 3,5-dibromo- and 2,3,5,6-tetrauoro-4-
hydroxy-benzoic acid (Fig. 1c). The theoretical pKa values of
these leaving groups are 5.72, 5.68, 5.59 and 4.17, and therefore
the expected order of the reactivity was 4 > 3 > 2 > 1. To evaluate
the effect of steric hindrance, we also prepared 5, having a
exible-type ethylene glycol linker between the reactive group
and Dc, or 6, having no linker. Additionally, acyl imidazole-type
control compound 7, having a TMP ligand and Dc uorophore
was prepared.5 The compounds were synthesized according to
the synthetic protocols shown in the ESI.† Unfortunately, we
could not isolate the tetrauoro-type reagent 4, because of the
low stability of this reactive group under the nal condensation
conditions.
Optimization of the reactivity of PE reagents in a test tube
In vitro experiments were rst conducted to examine which is
the best reactive group for rapid and selective labeling of
eDHFR. The labeling reactions of puried eDHFR (10 mM) with
Dc-appended PE reagents 1–3 (20 mM) were analyzed by SDS-
PAGE and uorescence gel imaging. As shown in Fig. 2a, uo-
rescence was clearly observed from the band for eDHFR aer a
3 h incubation with 2 or 3, whereas no uorescence was
observed upon incubation with 1. In addition, no signicant
bands were observed when eDHFR was incubated with 2 or 3 in
the presence of methotrexate (MTX, 100 mM), a strong inhibitor
of eDHFR, indicating that these labeling reactions were driven
by a specic ligand–protein interaction. The detailed labeling
kinetics, which were evaluated by MALDI-TOF MS analyses,
clearly showed that the initial rate of the labeling reaction with 3
was 3.4-fold faster than that with 2 (Fig. 2b and S1†). These
results showed that the ortho-dibromophenyl ester (di-Br) type
of reactive group was useful for LD chemistry. Next, the spacer
effect between Dc and the di-Br-type reactive group was evalu-
ated using 3, 5 and 6, which have an alkyl chain, oligoethylene
Fig. 1 Ligand-directed dibromophenyl benzoate (LDBB) chemistry for rapid and selective intracellular protein labeling. (a) Schematic illustration
of LDBB chemistry for chemical labeling of a protein of interest (POI) in living cells. (b) Design strategy for intracellular protein acylation; the
reactivity was tuned at position A (ortho-substituted phenyl ester moiety), and the stability was tuned at positions A and B (probe moiety). (c)
Chemical structures of reagents 1–6 for eDHFR containing TMP ligand and fluorophores, which were linked with various phenyl ester linkers (or
acyl imidazole-type reagent 7).
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glycol and no spacer, respectively. In all cases, the molecular
mass corresponding to Dc-labeled eDHFR was observed as
shown in Fig. 2b and S1.† The kinetic analyses of the labeling
using these reagents revealed that the initial rates of these
reactions were almost the same for all three reagents (0.14, 0.16
and 0.17 mM1 min1 for 3, 5 and 6, respectively, Fig. 2b). These
were over 7-fold faster than that obtained using acyl imidazole
reagent 7 (0.02 mM1 min1 for 7), indicating that this new LD
chemistry is more rapid than LDAI chemistry, at least in vitro.
We also conrmed that the reaction was site specic using 6 by
subjecting the Dc-labeled eDHFR to proteolytic digestion.
Conventional peptide mapping analysis revealed that Lys32,
located near the ligand-binding site, was predominantly modi-
ed (over 94%) by the acylation reaction (Fig. S2†).
Evaluation of the stability of LDBB reagents in vitro and the
reaction specicity under crude conditions
Next, we evaluated the stabilities of the reagents under the
labeling conditions using HPLC analyses. The half-lives of the
reagents in aqueous buffer were 19.5 h and 5.6 h for 3 and 5,
whereas only 10% of 6 was hydrolyzed even aer incubation for
13 h at 37 C (Fig. 2c and S3†). Moreover, upon the addition of
an esterase, 3 was completely decomposed aer 30 min of
incubation, whereas 20% of 6 remained aer 2 hours (Fig. 2c
and S3†). These results clearly indicated that 6 was resistant
toward both autolysis in aqueous buffer, and also catalytic
hydrolysis with esterase, maybe because of the steric hindrance
provided by the ortho-dibromophenyl benzoate (the CPK model
is shown in Fig. S4†). Overall, the results clearly demonstrated
that ligand-directed dibromophenyl benzoate (LDBB) reagent 6,
which is directly connected to Dc, has moderate reactivity
(derived from the leaving-group ability of dibromophenol) and
stability (derived from the sterically hindered benzoate struc-
ture) for use in a rapid and specic eDHFR labeling reaction in
vitro. To investigate the labeling selectivity of these reagents
under crude conditions, the reactions were carried out using
cell lysates of E. coli that overexpressed thioredoxin tag fused
eDHFR. A clear single uorescent band corresponding to tag-
fused eDHFR appeared when the cells were incubated with 6
(Fig. 2d). On the other hand, no detectable uorescence was
observed upon the addition of an excess amount of TMP,
indicating that this labeling reaction was driven by a specic
ligand–protein interaction. Using 3 or 5, the labeling yield was
apparently lower than using 6. Taken together, these results
showed that 6 is sufficiently stable and can label eDHFR
specically even in cell lysates containing various reactive
biomolecules.
eDHFR labeling with Dc-type reagents in living mammalian
cells
Having optimized the Dc-type of LDBB labeling reagent, we next
attempted to modify intracellular eDHFR in mammalian cells.
To assess the labeling specicity of the reagents, we used
human epithelial HeLa cells stably expressing eDHFR fused
with green uorescent protein (GFP) (HeLa-DG). The HeLa-DG
cells were incubated in a medium containing reagent 6 at 37 C,
and washed three times with fresh medium. The cells were then
lysed and analyzed by SDS-PAGE, uorescence gel imaging or
western blotting (Fig. 3 and S5†). Notably, a single uorescence
band corresponding to Dc-labeled eDHFR–GFP was detected,
Fig. 2 eDHFR-selective labeling in vitro. (a) SDS-PAGE analysis of the
covalent labeling of purified eDHFR with 1, 2, and 3 in a test tube.
Reaction conditions: eDHFR (10 mM) and labeling reagents (20 mM)
were incubated in the presence or absence of 100 mM MTX in 50 mM
HEPES buffer (pH 7.2) at 37 C. In lane 10, an independently prepared
Dc–eDHFR conjugate (60% yield) was used as a standard marker for
the determination of the labeling yields. The gel was analyzed by in-gel
fluorescence imaging (FL, lower), and stained with Coomassie brilliant
blue (CBB, upper). (b) (left) MALDI-TOF MS spectra of eDHFR (10 mM)
labeled with compound 6 (20 mM) in 50mMHEPES buffer (pH 7.2) at 37
C. denotes native eDHFR and denotes labeled eDHFR. (right) Time
profiles of eDHFR (10 mM) labeled with 1 ( ), 2 ( ), 3 ( ), 5 ( ), 6 ( ) and 7
(LDAI reagent, ) in buffer at 37 C. The labeling reaction was moni-
tored by MALDI-TOF MS analyses. (c) (left) HPLC charts of labeling
reagent 6 ( ) in buffer solution at 37 C for 0 h (top) or 13 h (bottom) of
incubation. denotes decomposed reagent 6. denotes the internal
standard. (right) HPLC analyses of the stability of labeling reagents 3, 5
and 6 in the absence ( ; 3, ; 5, ; 6) or presence ( ; 3, ; 6) of porcine
liver esterase (100 nM) in buffer solution at 37 C. (d) SDS-PAGE
analysis of the labeling of Trx–His6–eDHFR with 6 (10 mM) in E. coli
lysates.
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despite the presence of various other proteins as shown in the
CBB staining image. The addition of TMP ligand completely
blocked the labeling, which indicates that this modication
occurs via a specic ligand–eDHFR interaction even inside cells.
The labeling yield was determined to be 85  5% of the total
eDHFR–GFP, which was calculated from the uorescence
intensity of Dc and the chemiluminescence intensity of anti-
GFP antibody (Fig. S5c†). The time-dependence experiments
revealed that the new reagent 6 labeled 50% of eDHFR–GFP
with a t1/2 of 30 min (Fig. 3b). Conversely, several proteins other
than eDHFR–GFP were also labeled nonspecically by using 5,
whereas no eDHFR labeling was observed by using 3 (Fig. S6a†).
These results may be explained by the lower selectivity or
reactivity of reagents 3 and 5 compared with 6, similar to results
obtained for the in vitro experiments. In addition, LDAI reagent
7 did not label intracellular eDHFR–GFP (Fig. S6b†), perhaps
because of the lower stability or cellular permeability of this
reagent. Together, these results clearly demonstrated that the
rapid and quantitative labeling of an intracellular natural
protein could be achieved using LDBB chemistry in living
mammalian cells.
Live-cell imaging of native eDHFR by covalent modication of
a synthetic uorophore
The in-cell eDHFR–GFP labeling results led us to investigate
whether LDBB chemistry could be applied to intracellular
protein imaging by covalent modication of a synthetic uo-
rophore. HeLa-DG cells were incubated in amedium containing
reagent 6 (50 nM) for 3 h at 37 C, then washed three times with
fresh medium, and the cells were observed by confocal laser
scanning microscopy (CLSM). From the CLSM images of the
HeLa-DG cells using the GFP channel, eDHFR–GFP was found
to be distributed throughout the intracellular region, including
the cytosol and nuclei. As shown in Fig. 4a, the uorescence of
Dc was clearly detected inside the cells and merged with the
GFP image. However, before the labeling reaction, the addition
of TMP resulted in the disappearance of Dc uorescence
(Fig. 4b). These results clearly show that the new LDBB reagent
6 could be used to specically label and visualize intracellular
eDHFR–GFP using a synthetic uorophore.
To assess the applicability of uorophores other than Dc in
LDBB chemistry, we prepared two more uorophore-
Fig. 3 Intracellular eDHFR–GFP labeling with optimized reagent 6 in
HeLa-DG cells. (a) SDS-PAGE analyses of the labeling reaction of 6 (1
mM) in HeLa-DG cells. The gel was analyzed by in-gel fluorescence
imaging (right) and stainedwith CBB (left). Lane 6 shows the reaction in
the presence of TMP (10 mM). (b) Time course of eDHFR–GFP labeling
in HeLa-DG cells. The fluorescence intensity (I) was normalized using
the intensity for 8 h of incubation (I8h). The experiments were per-
formed in triplicate to obtain mean and standard deviation values
(shown as error bars).
Fig. 4 (a and b) Live-cell imaging of eDHFR–GFP with 6 (50 nM) in the
absence (a) or presence (b) of TMP (50 mM) in HeLa-DG cells. Fluo-
rescence images of GFP, Dc and their merged phase contrast images
are displayed in the left, middle and right of each panel, respectively.
Images of Dc were obtained at an excitation of 405 nm using a 420–
480 nm emission filter, those of GFP were obtained at an excitation of
473 nm using a 490–520 nm emission filter. Scale bar: 20 mm.
Fig. 5 (a) Chemical structures of LDBB reagents 8 and 9. (b) Live-cell
imaging of eDHFR–GFP with 8 (20 nM) in HeLa-DG cells. Fluores-
cence images of GFP, TMR and their merged phase contrast images
are displayed in the left, middle and right of each panel, respectively.
Images of GFP were obtained at an excitation of 473 nm using a 490–
520 nm emission filter and those of TMR were obtained at an excita-
tion of 559 nm using a 570–670 nm emission filter, respectively. (c)
Live-cell imaging of eDHFR-CFP by 9 (50 nM) in HeLa cells expressing
eDHFR-CFP. Fluorescence images of CFP, fluorescein (FL) and their
merged differential interference contrast images are displayed in the
left, middle and right of each panel, respectively. Images of CFP were
obtained at an excitation of 457 nm using a 470–490 nm emission
filter and those of fluorescein (FL) were obtained at an excitation of 515
nm using a 520–620 nm emission filter. Scale bar: 20 mm.
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appended reagents for the labeling of intracellular
eDHFR (Fig. 5a, tetramethylrhodamine (TMR, 8) and acetyl-
uorescein (AcFl, 9)), according to the molecular design
principle of LDBB chemistry as discussed above.13,14 Fig. 5b
shows that the TMR-type of reagent 8 was useful to visualize
the localization of eDHFR–GFP in live HeLa-DG cells to a
similar degree as 6. Reagent 9 can also label and image cyan
uorescent protein-fused eDHFR (eDHFR-CFP), which was
transiently expressed in live HeLa cells (Fig. 5c) (we chose CFP
as an alternative marker to GFP because the emissions of
uorescein and GFP overlap). These results clearly show that
LDBB chemistry is suitable for uorescent live-cell imaging of
intracellular natural protein with blue, green and red emis-
sion, and this imaging tool may be applicable for concomitant
use with various other imaging technologies, such as uo-
rescent protein tags or organelle staining probes.
Endogenous intracellular protein labeling and imaging using
a LDBB reagent
Finally, we attempted to label “endogenous” protein in live cells
by altering the affinity ligand, owing to the modular design of
LDBB reagents. Human carbonic anhydrase II (hCAII), a cyto-
solic protein, and XII (hCAXII), a membrane-bound protein,
were chosen as the target proteins endogenously expressed in
MCF7 cells (breast cancer cell line). Accordingly, we synthesized
the new AcFl-type LDBB reagent 10 containing benzenesulfo-
namide as the selective ligand for the hCA family (Fig. 6a, Ki of
260 nM).15,16 MCF7 cells were incubated with 10 at 37 C, and
then the labeling of hCA was evaluated by western blotting
analyses. Fig. 6b shows that aer only 15 to 30 min of incuba-
tion, two distinct bands could be detected at 30 kDa and 50
kDa using anti-uorescein antibody, corresponding to the band
obtained from western blotting with the anti-hCAII antibody
(30 kDa) and anti-hCAXII antibody (50 kDa). No band was
observed in the presence of ethoxzolamide (EZA, a strong
inhibitor of the hCA family of enzymes), which clearly demon-
strated that 10 can covalently label not only intracellular hCAII
but also cell-surface hCAXII with strict specicity in live cells.17
Using the SA-type LDBB reagent in vitro, the labeling sites for
hCAI or II were identied as Lys171 or Lys169/His3, respectively
(Fig. S9 and S10†). These amino acids were again located near
the binding site of each target protein (Fig. S9e and S10e†),
demonstrating that the LDBB reagents were able to react not
only with lysine, but also with (at least) histidine, based on the
proximity effect. These results also implied the general appli-
cability of the LDBB chemistry for the efficient labeling of
various proteins having nucleophilic amino acids appropriately
located near the ligand binding site. The CLSM images also
showed that strong uorescence was clearly observed from both
the cell membrane and cytosolic part of MCF7 cells. In contrast,
no uorescence was detected in the presence of EZA. Taken
together, these results clearly demonstrate that the LDBB
chemistry is a sufficiently rapid, efficient and specic labeling
technique for endogenous protein imaging both on the cell
surface and inside the cell.
Conclusion
Herein, we demonstrated that LDBB chemistry is useful for the
selective and rapid labeling of not only overexpressed proteins,
but also endogenous proteins in mammalian cells. By nely
tuning the reactivity and stability of the phenyl ester moiety, it
was found that ortho-dibromophenyl benzoate was sufficiently
stable in aqueous buffer (decomposed less than 10% aer 13 h
incubation), yet highly reactive in living cells and in vitro
Fig. 6 (a) Chemical structure of reagent 10, having a benzenesulfo-
namide (SA) ligand for hCA labeling. (b) Western blotting analyses of
the labeling of endogenous hCA with 10 (100 nM) in living MCF7 cells,
detected with anti-fluorescein antibody (top), anti-hCAXII antibody
(middle) and anti-hCAII antibody (bottom). The band with a single
asterisk (*) corresponds to hCAII, the double asterisk (**) corresponds
to hCAXII and the triple asterisk (***) corresponds to a non-specifi-
cally-labeled BSA derived from the cultured medium. (c and d) Live-
cell imaging of hCA labeling with 10 (100 nM) in MCF7 cells in the
absence (c) or presence (d) of EZA (100 mM). Fluorescence images and
phase contrast images of fluorescein (FL) are displayed in the left and
right of each panel, respectively. Scale bar: 30 mm.
This journal is © The Royal Society of Chemistry 2015 Chem. Sci., 2015, 6, 3217–3224 | 3221





















































































(over 85% labeling yield was achieved for overexpressed eDHFR
in mammalian cells). Moreover, owing to the reactive amino
acid preferences and the modular design principle, the LDBB
reagents can label various natural (or engineered) proteins
having nucleophilic amino acids (including at least lysine and
histidine) located near the ligand binding site, as shown in the
cases of the labeling of eDHFR and hCAs.11c The present study
also showed that LDBB chemistry is a powerful tool for natural
protein imaging in living mammalian cells, because of the fact
that various benzoate-type uorophores (including Dc, FL and
TMR) can be easily installed on the target proteins with suffi-
cient selectivity and rapidity. We envision that the extension of
this ligand-directed chemistry should allow for multi-color
imaging of various endogenous proteins and analyses of
protein–protein interactions in living cells in the future.
Experimental procedures
Synthesis
All synthetic procedures and compound characterization are
described in the ESI.†
General materials and methods
All chemical reagents and solvents were obtained from
commercial suppliers (Aldrich, Tokyo Chemical Industry (TCI),
Wako Pure Chemical Industries, Acros Organics, Sasaki
Chemical, or Watanabe Chemical Industries) and used without
further purication. UV-visible spectra were recorded on a
Shimadzu UV-2550 spectrometer. All reactions were carried out
under an atmosphere of argon or nitrogen unless otherwise
noted. Thin layer chromatography (TLC) was performed on
silica gel 60 F254 precoated aluminum sheets (Merck) and
visualized by uorescence quenching or ninhydrin staining.
Chromatographic purication was accomplished using ash
column chromatography on silica gel 60 N (neutral, 40–50 mm,
Kanto Chemical). 1H NMR spectra of samples were recorded on
Varian Mercury 400 (400 MHz) spectrometers. 13C NMR spectra
of samples were recorded on Jeol ECX-400P (100 MHz) spec-
trometers. IR spectra were recorded on a JASCO FT/IR-410.
Matrix-assisted laser desorption/ionization time-of-ight mass
spectrometry (MALDI-TOF MS) spectra were recorded on an
Autoex III instrument (Bruker Daltonics) using a-cyano-4-
hydroxycinnamic acid (CHCA) as the matrix. High-resolution
mass spectra were measured on an Exactive (Thermo Scientic,
CA, USA) equipped with electron spray ionization (ESI). SDS-
PAGE and western blotting were performed using a Bio-Rad
Mini-Protean III electrophoresis apparatus. Fluorescence and
chemical luminescent signals were detected with Imagequant
LAS 4000 (GE Healthcare).
In vitro labeling of eDHFR
E. coli DHFR (eDHFR) was prepared and puried as previously
reported.18 Briey, thioredoxin- and His-tag fused eDHFR (Trx–
His6–eDHFR) was puried with TALONmetal affinity resin, and
the puried proteins were subjected to site-specic cleavage
with thrombin, and then puried with TALON metal affinity
resin and benzamidine sepharose to remove Trx-His6 and
thrombin. The concentration of eDHFR was determined by
absorbance at 280 nm using a molar extinction coefficient of
31 100 M1 cm1. The solution of eDHFR (10 mM) was incu-
bated with the labeling reagent (20 mM) in the absence or
presence of MTX (100 mM) in 50 mM HEPES buffer (pH 7.2) and
incubated at 37 C. Aliquots were taken at different time points,
mixed with MTX (100 mM), and subjected to SDS-PAGE analyses.
Fluorescence gel images were acquired using a Bio-Rad Chem-
iDoc XRS system with a 480BP80 lter, and analyzed with
Quantity One 1-D Analysis Soware (Bio-Rad Laboratories). In
separate experiments using MALDI-TOF MS analyses (matrix,
sinapinic acid), the labeling yield was estimated by determining
the relative MS peak intensity of labeled eDHFR to unreacted
eDHFR. Aliquots were taken at different time points, quenched
by using ZipTip purication with 0.1% TFA aq., and spotted
onto a MALDI plate with the matrix solution.
In cell labeling of eDHFR
Before labeling, HeLa-DG cells (6  105 cells) were seeded in a
35 mm dish, incubated in DMEM (10% fetal bovine serum
(FBS)) for 24 h at 37 C, and then washed three times with
phosphate buffered saline (PBS). The cells were treated with the
LDBB reagent (100 or 500 nM) at 37 C in DMEM (FBS free,
1 mL) and incubated. As a control experiment, the labeling was
conducted in the presence of TMP (10 mM, pre-incubated for
5 min). Aer labeling, the cells were washed three times with
PBS, and then RIPA buffer (pH 7.4, 25 mM Tris–HCl, 150 mM
NaCl, 0.1% SDS, 1% Nonidet P-40, 0.25% deoxycholic acid) was
added containing 1% protease inhibitor cocktail set III
(Calbiochem®) and 10 mMMTX. The lysed sample was collected
and centrifuged (10 000 g, 10 min at 4 C). The supernatant was
mixed with the same volume of 2 sampling buffer (pH 6.8, 125
mM Tris–HCl, 20% glycerol, 4% SDS, 0.01% bromophenol blue,
8% 2-mercaptoethanol) and incubated for 5 min at 95 C. The
samples were subjected to SDS-PAGE (12.5%) and in-gel uo-
rescence images were obtained. In the live cell imaging experi-
ments, the cells (2  105 cells, pre-cultured for 24 h in a 35 mm
glass bottomed dish) were washed three times with PBS, and
then treated with LDBB reagent 6 (50 nM) at 37 C in DMEM
(FBS free, 1 mL) and incubated for 8 h. Aer removing the
medium, the cells were treated with DMEM (10% FBS) for 3 h,
and then subjected to imaging analysis using a CLSM (Olympus,
FLUOVIEW FV10i). Images of Dc were obtained at an excitation
of 405 nm using a 420–480 nm emission lter, and those of GFP
were obtained at an excitation of 473 nm using a 490–520 nm
emission lter. For the TMR-type reagent 8, the HeLa-DG cells
were labeled with 8 (20 nM) at 37 C in DMEM (FBS free, 1 mL)
and incubated for 3 h. Aer removing the medium, the cells
were treated with DMEM (10% FBS) for 5 h, and then subjected
to imaging analysis using a CLSM (FV10i). Images of GFP were
obtained at an excitation of 473 nm using a 490–520 nm
emission lter and those of TMR were obtained at an excitation
of 558 nm using a 570–670 nm emission lter, respectively. For
the AcFl-type reagent 9, the normal HeLa cells (2  105 cells)
were cultured in DMEM (10% FBS) in a 35 mm glass-bottomed
3222 | Chem. Sci., 2015, 6, 3217–3224 This journal is © The Royal Society of Chemistry 2015





















































































dish at 37 C for 24 h. The cells were transiently transfected with
the peDHFR-ECFP plasmid using a FuGENE HD (Promega).
Aer 24 h of transfection, the cells were labeled with 9 (50 nM)
at 37 C in DMEM (FBS free, 1 mL) and incubated for 3 h. Aer
removing the medium, the cells were treated with DMEM (10%
FBS) for 5 h, and then subjected to imaging analysis using a
CLSM (Olympus, FLUOVIEW FV1000). Images of CFP were
obtained at an excitation of 457 nm using a 470–490 nm
emission lter, and those of uorescein (FL) were obtained at
an excitation of 515 nm using a 520–620 nm emission lter.
In vitro labeling of hCAI and II
Human carbonic anhydrase I and II (hCAI, II) were purchased
from SIGMA-Aldrich, and used without further purication. The
concentrations of hCAI and II were determined by absorbance
at 280 nm using a molar extinction coefficient of 49 000 M1
cm1 for hCAI and 54 000 M1 cm1 for hCAII in 50 mMHEPES
buffer (pH 7.4, 100 mMNaCl). The solution of hCAI or II (20 mM)
was incubated with labeling reagent 11 (40 mM) at 37 C. Aer
10 h, the labeling reaction was conrmed with MALDI-TOF MS
analyses (matrix: sinapinic acid), and the labeling yield was
determined to be 46% for hCAI and 38% for hCAII. Aer
labeling, the protein was puried with gel ltration (TOYO
PEARL). To this solution was added urea (at a nal concentra-
tion of 2 M) and lysyl endopeptidase (LEP) (LEP/substrate ratio
¼ 1/30 (w/w)). Aer incubation at 37 C overnight, the digested
samples were used for RP-HPLC. The collected fractions were
analysed by MALDI-TOF MS using CHCA as the matrix and the
labeled fragment was further characterized by MALDI TOF-TOF
MS/MS (Bruker Daltonics) or MALDI-LTQ-Orbitrap-MS/MS
(Thermo Scientic, CA, USA).
In cell labeling of hCAII and XII
Before labeling, MCF7 cells (2  105 cells) were seeded in a 35
mm dish, incubated in DMEM (10% fetal bovine serum (FBS))
for 24 h at 37 C, and then washed three times with DMEM (FBS
free). The cells were treated with LDBB reagent 10 (100 nM) at 37
C in DMEM (FBS free, 1 mL) and incubated. As a control
experiment, the labeling was conducted in the presence of EZA
(100 mM, pre-incubated for 5 min). Aer labeling, the cells were
washed three times with PBS, and then RIPA buffer was added
containing 1% protease inhibitor cocktail set III (Calbiochem)
and 100 mM EZA. The lysed sample was collected and centri-
fuged (10 000 g, 10 min at 4 C). The supernatant was mixed
with the same volume of 2 sampling buffer (pH 6.8, 125 mM
Tris–HCl, 20% glycerol, 4% SDS, 0.01% bromophenol blue, 100
mM DTT) and vortexed for 1 h at room temperature. The
samples were resolved by 12.5% SDS-PAGE and electro-
transferred onto an Immun-Blot PVDF membrane (Bio-Rad).
The labeled products were detected with anti-uorescein anti-
body (Abcam, 3000) and anti-rabbit IgG antibody–HRP
conjugate (GE Healthcare, 5000). The immunodetection of
hCAII used an anti-hCAII antibody (Abcam, 2000) and anti-
rabbit IgG antibody–HRP conjugate (GE Healthcare, 5000).
The immunodetection of hCAXII used an anti-hCAXII antibody
(Cellsignaling, 2000) and anti-rabbit IgG antibody–HRP
conjugate (GE Healthcare,5000). The HRP signal was detected
with a LAS 4000 imaging system (FujiFilm) using ECL plus
western blotting detection reagents (GE Healthcare). In the live
cell imaging experiments, the MCF7 cells (2  105 cells, pre-
cultured for 24 h in a 35 mm glass-bottomed dish) were washed
three times with DMEM (FBS free), and then treated with LDBB
reagent 10 (100 nM) at 37 C in a DMEM (FBS free, 1 mL) and
incubated for 1 h. Aer removing the medium, the cells were
washed three times with DMEM (10% FBS), and then subjected
to imaging analysis using a CLSM (Olympus, FLUOVIEW FV10i).
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